No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

Abroad (travel likely)Recruiting

Conditions

No-Reflow · STEMI · Intracoronary · Tirofiban

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Kafrelsheikh University, Kafr ash Shaykh, Kafrelsheikh, Egypt
Contact: Study coordinator (Mohammed A Hammad, MD) · drhammad879@gmail.com · 00201015928694
Contact: Principal Investigator (Wael A Hassib, MD)
Contact: Principal Investigator (Mohamed K Salama, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

ST-Segment Elevation Myocardial Infarction (STEMI) · No-Reflow Phenomenon · Coronary Slow Flow

Abroad (travel likely)RecruitingPHASE4

Karachi, Pakistan · Karachi, Pakistan

The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow

ST Segment Elevation Myocardial Infarction (STEMI) · No Reflow Phenomenon

Abroad (travel likely)RecruitingPHASE3

Cairo, Egypt

A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

No-Reflow Phenomenon · Coronary Artery Disease · Percutaneous Coronary Intervention

Abroad (travel likely)RecruitingPHASE4

Seoul, South Korea